Dental management of patients with human immunodeficiency virus

Quintessence International

Volumn 34, Issue 7, 2003, Pages 515-525

  Campo Trapero, Julián ^a   Cano Sánchez, Jorge ^c   Del Romero Guerrero, Jorge ^b   Moreno López, Luis A ^a   Cerero Lapiedra, Rocío ^a   Bascones Martínez, Antonio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Sandoval Health Centre   (Spain)

^c Universidad Complutense de Madrid ^*

Author keywords

AIDS; Dental care; Dental implantation; HIV; Odontologic treatment

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ACICLOVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; CARBAMAZEPINE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FOSCARNET; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; INDINAVIR; KETOCONAZOLE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; METRONIDAZOLE; NELFINAVIR; NEVIRAPINE; PENTAMIDINE; PROTEINASE INHIBITOR; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; SULFONYLUREA DERIVATIVE; TENOFOVIR; TENOFOVIR DISOPROXIL; TETRACYCLINE; UNINDEXED DRUG; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; BACTERIUM CULTURE; BLEEDING TIME; CHEILITIS; CLINICAL TRIAL; DENTAL CARE; DENTAL CARIES; DENTIST; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; ENDODONTICS; ERYTHEMA MULTIFORME; EVALUATION; GASTROINTESTINAL HEMORRHAGE; GINGIVA DISEASE; HEMOSTASIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERPIGMENTATION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LIPOMATOSIS; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MOUTH HYGIENE; MOUTH ULCER; NERVE INJURY; NEUTROPENIA; ORAL SURGERY; PARESTHESIA; PAROTID GLAND DISEASE; PERIODONTAL DISEASE; PNEUMOCYSTIS CARINII; PNEUMONIA; PREVENTIVE DENTISTRY; REVIEW; RISK FACTOR; SEROLOGY; SIDE EFFECT; T LYMPHOCYTE; TASTE DISORDER; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TOOTH EXTRACTION; TOOTH IMPLANTATION; VAGINA CANDIDIASIS; VIRUS LOAD; WOUND HEALING; XEROSTOMIA;

ANTI-HIV AGENTS; DENTAL CARE FOR CHRONICALLY ILL; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; INFECTION CONTROL, DENTAL;

EID: 0141426604     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Joint United Nations Programme on HIV/AIDS. Report on the global HIV/ AIDS epidemic. Available at: www.unaids.org Accessed December 12, 2002.
2. Diz P, Vázquez E, Fernández J, Porter S. Tratamiento odontológico del paciente infectado por el VIH. Medicina Oral 1998;3:222-229.
3. Vázquez-Garcia E, Diz Dios P, Fernández-Feijoo J, Alvarex-Alvarez J, Castro-Ferreiro M, Campo-Hermida A. Actitudes de los pacientes VIH-positivos hacia los cuidados odontológicos. Revista Europea de Odonto-Estomatología 1997;9:46-50.
4. McCarthy GM, Haiji FS, Mackie ID. Attitudes and behavior of HIV-infected patients concerning dental care. J Cal Dent Assoc 1996;62:63-69.
5. Porter SR, Luker J, Scully C. Demographics of HIV-infected persons attending a dental clinic. Br Dent J 1996;180:303-306.
6. Romero A, López J, Gimenez MJ, Chimenos E. Tratamiento odontológico en el paciente VIH+ ¿Una prioridad médica asistencial? Arch Odontoestomatol 1999;15(10):433-440.
7. Cisterna JR. Infecciones del aparato respiratorio. Madrid: Emisa, 1990.
8. Morillo JM, Fernández-Prada CM. Asistencia odontológica de la persona seropositiva. Maxillaris 1999;1:36-39.
9. Greksa LP, Parraga I, Clark CA. The dietary adequacy of edentulous older adults. J Prosthet Dent 1995;73:142-145.
10. Joshipura KJ, Willet WC, Douglass CW. The impact of edentulousness on food and nutrient intake. J Am Dent Assoc 1996;127:459-467.
11. Hardie J. Problems associated with providing dental care to patients with HIV-infected and AIDS patients. Oral Surg Oral Med Oral Pathol 1992;73:231-235.
12. Vázquez-Garcia E, Diz Dios P, Batalla-Vázquez P, Castro-Ferreiro M, Alvarez-Alvarez J, Fernández-Feijoo J. Actitudes de los profesionales odontólogos ante el paciente infectado por el VIH. Revista Europea de Odonto Estomatología 1996;8:277-282.
13. Sadowsky D, Kunzel C. Measuring dentist's willingness to treat HIV-positive patients. J Am Dent Assoc 1994;125:705-710.
14. Bell DM. Occupational risk of human immunodeficiency virus infection in healthcare workers: An overview. Am J Med 1997;102(suppl 5B):9-15.
15. Ippolito G, Puro V, De Carli G. Italian study group on occupational risk of HIV infection. The risk of occupational human immunodeficiency virus in health care workers. Arch Int Med 1993;153:1451-1458.
16. Evans BG, Abiteboul D. Resumen de infecciones ocupacionales por VIH descritas en informes publicados hasta diciembre de 1997. Eurosurveillance 1999;4:29-32.
17. Scully C, Porter S. The level of risk transmission of human immunodeficiency virus between patients and dental staff. Br Dent J 1991;170:97-100.
18. Centers for Disease Control. Recommended infection control practices for dentistry. MMWR 1993;42(8):1-12.
19. Little JW, Falace DA, Miller CS, Rhodus NL. Tratamiento odontológico del paciente bajo tratamiento médico, ed 5. Madrid: Harcourt Brace, 1998.
20. Centers for Disease Control. Guidelines for Prevention of transmission of HIV and HBV to health-care and public safety workers. MMWR 1989;38:1-37.
21. Avery CM, Gallagher P, Birnbaum W. Double gloving and a glove perforation indication system during the dental treatment of HIV-positive patients: Are they necessary? Br Dent J 1999;186:27-29.
22. Centers for Disease Control. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR 2001;50(11):1-42.
23. Barr CE. Consideraciones prácticas en el tratamiento del sujeto infectado por el virus de inmunodeficiencia humana (HIV). Clínicas Odontológicas de Norteamérica 1994;3:379-400.
24. Centers For Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(17):1-20.
25. Troisi CL, Hollinger B, Hoots WK, et al. A multicenter study of viral hepatitis in United States hemophilic population. Blood 1993;81(2):412-418.
26. Donahue JG, Nelson KE, Munos A, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991;134:1206-1211.
27. Haverkos HW, Lange RW. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990;161:894-902.
28. Del Romero J, García S, Rodríguez C, et al. Prevalencia de coinfección por el virus de la hepatitis C y el virus de la inmunodeficiencia humana en usuarios de drogas inyectadas y en mujeres que ejercen la prostitución. Enfermedades de Transmisión Sexual 2000;12:59-63.
29. Dajani AS, Tauber KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendation by the American Heart Association. J Am Med Assoc 1997;277:1794-1801.
30. Glick M, Garfunkel AA. Common oral findings in two different diseases-Leukemia and AIDS. Part I. Compend Contin Educ Dent 1992;13:432-439.
31. Campo J. Relación de los Parámetros Inmunológicos y Virológicos con la Aparición de Candidosis Oral en el Paciente VIH-positivo [thesis]. Madrid: Complutense University of Madrid, 1999.
32. Glick M, Muzyka BC, Lurie D, et al. Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS. Oral Surg Oral Med Oral Pathol 1994;77:344-349.
33. Harbol AW, Liesveld JL, Simpsom-Haidaris PD, et al. Mechanisms of cytopenia in Human Immunodeficiency Virus Infection. Blood Reviews 1994;8:241-251.
34. Dodson TB, Perrot DH, Gongloff RK, et al. Human immunodeficiency virus serostatus and the risk of postextraction complications. Int J Oral Maxillofac Surg 1994;21:100-103.
35. Diz Dios P, Vazquez Garcia E, Feijoo J. Dental extractions performed in HIV-positive patients. J Dent Res 1998;77:533-534.
36. Rajnay ZW, Hochstetter RL. Immediate placement of an endosseous root-form implant in a HIV-positive patient: Report of a case. J Periodontol 1998;69(10):1167-1171.
37. Malagón S, Chimenos E, López J, et al. Protocolo del manejo odontoestomatológico de pacientes infectados por el VIH(I). Publicación oficial de SEISIDA 1997;8(1):21-24.
38. Malagón S, Chimenos E, López J, et al. Protocolo del manejo odontoestomatológico de pacientes infectados por el VIH(II). Publicación oficial de SEISIDA 1997;8(2):63-66.
39. Centers for Disease Control. Guidelines for the use of antiretroviral agents in HIV-Infected Adults and Adolescents. U.S. Department of Health and Human Services (DHHS). Available at: www.hivatis.org Accessed March 13, 2003.
40. Scully C, Diz Dios P. Orofacial effects of antiretroviral therapies. Oral Dis 2001;7:205-210.
41. Greenwood I, Heylen A, Zakrzewska JM. Anti-retroviral drugs implications for dental prescribing. Br Dent J 1998;184:478-482.
42. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 2000;356:1423-1430.
43. Casariego Z, Pombo T, Pérez H, Patterson P. Queilitis eruptiva: Un nuevo efecto adverso en pacientes VIH+ bajo tratamiento antirretroviral combinado (HAART). Presentación de 6 casos clínicos. Medicina Oral 2001;6:19-30.
44. Medina I, Mills J, Leoung G, et al. Oral therapy for Pneumocystis carinii pneumonia in the aquired immune deficiency syndrome: A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 1990;323:776-781.
45. Bayard PJ, Berger TG, Jacobsen MA. Drug hypersensitivity reactions and HIV disease. J AIDS 1992,5:1237-1245.
46. Harb GE, Alldredge BK, Coleman R, et al. Pharmacoepidemiology of adverse drug reactions in hospitalized patients with HIV disease. J AIDS 1993;6:919-926.
47. Engelhard D, Stutman HR, Marks MI. Interaction of ketaconazole with rifampin and isoniazid. N Engl J Med 1984;311:1681-1683.
48. Doweiko JP. Hematologic aspects of HIV infection. AIDS 1993;7:753-757.
49. Dodson TB. HIV status and the risk of post-extraction complications. J Dent Res 1997;76:1644-1652.
50. Dodson TB. Predictors of postextraction complications in HIV-positive patients. Oral Surg Oral Med Oral Pathol 1997;84:474-479.
51. Rarrick MU, Burian P, De Guzman N, et al. Intravenous immune globulin use in patients with HIV related thrombocytopenia who require dental extraction. West J Med 1991;155:610-612.
52. Patton L. Hematologic abnormalities among HIV-infected patients: Associations of significance for dentistry. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:561-567.
53. Coyle TE. Hematologic complications of HIV and AIDS. Med Clin North Am 1997;81:449-470.
54. American Academy of Oral Medicine. Dental treatment Considerations. Treatment planning and Ongoing Care. Dental Management of HIV-infected patients. Available at: www.hivdent.org/dtctreatmen.htm Accessed March 13, 2003.
55. Weibert RT. Oral anticoagulant therapy in patients undergoing dental surgery. Clin Pharm 1992;11:857-864.
56. Barrero MV, Knezevic M, Tapia M, et al. Cirugía oral en pacientes en tratamiento con anticoagulantes orales. Pauta de actuación. Medicina Oral 2002;7:63-70.
57. Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Relates to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. J Oral Pathol Med 1993;22:289-291.
58. Bartlet JG. The Medical Management of HIV Infection. Baltimore: Johns Hopkins University Press, 1998.
59. Glick M. Función del odontólogo en la era del SIDA. Clínicas Odontológicas de Norteamérica 1996;2:335-349.
60. Sjamsoedin DAS, Schulten EAJM, van der Waal I. Dental treatment in HIV infection: Experience with 250 patients in The Netherlands. Third International Workshop on the Oral Manifestations of HIV Infection. London, 1996:98.
61. Chimenos E. Tratamiento de las lesiones bucales más frecuentes, en pacientes VIH positivos. Av Odontoestomatol 1997;13(suppl A):129-137.
62. Barr CE, Rua Dobles A, Puig N. Comparing dental treatment in HIV-positive and HIV-negative control patients. J Dent Res 1989;68:298-302.
63. Yee J, Cristou NV. Perioperative care of the immunocompromised patient. World J Surg 1993;17:207-214.
64. Ficarra G. Oral lesions of iatrogenic and undefined etiology and neurologic disorders associated with HIV infection. Oral Surg Oral Med Oral Pathol 1992;73:201-211.
65. Martínez-Gimeno C, Acero J, Martínez R, Navarro C. Maxillofacial trauma: Influence of HIV infection. J Cranio Maxillofac Surg 1992;20:297-302.
66. Porter SR, Scully C, Luker J. Complications of dental surgery in persons with HIV disease. Oral Surg Oral Med Oral Pathol 1993;75:165-167.
67. Glick M, Abel SN, Muzika BC, DeLorenzo M. Dental complications after treating patients with AIDS. J Am Dent Assoc 1994;125:296-301.
68. Oikarinen K, Rasanen A. Complications of third molar surgery among university students. J Am Coll Health 1991;39(6):281-285.
69. Ferreira S, Pérez MA, Silva A Jr, et al. Postextraction complications in persons with HIV disease. Third International Workshop on the Oral Manifestations of HIV Infection. London, 1996:9,11.
70. Glick M. Dental Management of Patients with HIV, ed 1. Chicago: Quintessence, 1994.
71. Pankhurst CL, Lewis DA, Clark DT. Prophylactic application of intra-alveolar socket medicament reduce postextraction complications in HIV-seropositive patients. Oral Surg Oral Med Oral Pathol 1994;77:331-334.
72. Croser D, Erridge F, Robinson P. HIV and Dentistry. A Guide to Dental Treatment for Patients with HIV and AIDS. London: British Dental Association, 1994.
73. Luker J. Oral health care for HIV-positive individuals. In: Porter SR, Scully C (eds). Oral Health Care for Those with HIV Infection and Other Special Needs, ed 1. Northwood: Science Reviews, 1995:69-73.
74. Diz Dios P, Fernández Feijoo J, Vazquez Garcia E. Tooth extraction in HIV sero-positive patients. Int Dental J 1999;49:317-321.
75. Ramstróm G, Sindet-Pedersen S, Hall G, Blombäck M, Alander U. Prevention of postsurgical bleeding in oral surgery using tranexamic acid without dose modification of oral anticoagulants. J Oral Maxillofac Surg 1993;51:1211-1216.
76. Borea G, Montebignoli L, Capuzzi P, Magelli C. Tranexamic acid as a mouthwash in anticoagulant-treated patients undergoing oral surgery. Oral Surg 1993;75:29-31.
77. Winkler JR, Murray PA, Grassi M, Hämerle C. Diagnosis and management of HIV-associated periodontal lesions. J Am Dent Assoc 1989;118:25-34.
78. Murray PA, Grassi M, Winkler JR. The microbiology of HIV-associated periodontal lesions. J Clin Periodontol 1989;16:636-642.
79. Murray PA. Periodontal diseases in patients infected by human immunodeficiency virus. Periodontology 2000 1994;6:50-67.
80. Lucartoto FM, Franker CK, Maza J. Postscaling bacteremia in HIV-associated gingivitis and periodontitis. Oral Surg Oral Med Oral Pathol 1992;73:550-554.
81. Diz Dios P. Current classifications of HIV-associated periodontal disease. Br Dent J 1993;174:313-314.
82. Tukutuku K, Muyembe-Tamfum L, Kayembe K, Mavuemba T, Sangua N, Sekele I. Prevalence of dental caries, gingivitis, and oral hygiene in hospitalized AIDS cases in Kinshasa, Zaire. J Oral Pathol Med 1990;19:271-272.
83. Diz Dios P, Wächter R, Ponce AR, Feijoo J, Alvarez FJ, Castro M. Lesiones periapicales en pacientes con SIDA: Consideraciones histopatológicas, inmunopatológicas y terapéuticas. Endodoncia 1995;60:165-170.
84. Management of Dental Patients Who are HIV Positive. Summary, Evidence Report/Technology Assessment: number 37.AHRQ Publication No. 01-E041, March 2001. Available at: http://www.ahrq.gov/clinic)denthivsum.htm Accessed: May 15, 2001.